Literature DB >> 29240258

DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.

Tove Ullmark1, Giorgia Montano1, Urban Gullberg1.   

Abstract

The Wilms' tumour gene 1 protein (WT1) is a zinc finger transcription factor found indispensable for foetal development. WT1 has also been implicated in the development of tumours in several organ systems, including acute myeloid leukaemia (AML). Four main WT1 isoforms come from 2 alternative splice events. One alternative splice results in the inclusion or exclusion of 3 amino acids, KTS, between zinc fingers 3 and 4 in the WT1 protein. The KTS insert has been extensively investigated due to the functional implications for DNA and RNA binding. In this review, we provide an overview of the research into the isoforms containing or lacking the KTS insert in leukaemic cells, as well as the research into the binding patterns of the WT1 -KTS and +KTS isoforms to DNA and RNA. Finally, we connect the results of the DNA binding research to the ChIP-CHIP and ChIP-Seq investigations into the global genomic binding of the WT1 protein that have recently been performed.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute lymphoblastic leukemia; acute myeloid leukemia; hematopoiesis and hematopathology; molecular biology of myelopoiesis

Mesh:

Substances:

Year:  2018        PMID: 29240258     DOI: 10.1111/ejh.13010

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.

Authors:  Stefanie Kreutmair; Dietmar Pfeifer; Miguel Waterhouse; Ferenc Takács; Linda Graessel; Konstanze Döhner; Justus Duyster; Anna Lena Illert; Anna-Verena Frey; Michael Schmitt; Michael Lübbert
Journal:  Cancer Immunol Immunother       Date:  2022-04-27       Impact factor: 6.630

2.  Alteration in DNA-binding affinity of Wilms tumor 1 protein due to WT1 genetic variants associated with steroid - resistant nephrotic syndrome in children.

Authors:  Martin Bezdicka; Filip Kaufman; Ivana Krizova; Alzbeta Dostalkova; Michaela Rumlova; Tomas Seeman; Karel Vondrak; Filip Fencl; Jakub Zieg; Ondrej Soucek
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

3.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

Review 4.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

5.  Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.

Authors:  Jiajia Li; Haiying Li; Weijian Zhu; Bin Zhou; Jianchao Ying; Jiansheng Wu; Huxiang Zhang; Hongwei Sun; Shenmeng Gao
Journal:  J Cell Mol Med       Date:  2019-12-17       Impact factor: 5.310

6.  Whole exome sequencing identified a rare WT1 loss-of-function variant in a non-syndromic POI patient.

Authors:  Yingchen Wang; Qing Chen; Feng Zhang; Xi Yang; Lingyue Shang; Shuting Ren; Yuncheng Pan; Zixue Zhou; Guoqing Li; Yunzheng Fang; Li Jin; Yanhua Wu; Xiaojin Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-11-29       Impact factor: 2.183

Review 7.  Biological effects and regulation of IGFBP5 in breast cancer.

Authors:  Jürgen Dittmer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

8.  A Novel WT1 Mutation Identified in a 46,XX Testicular/Ovotesticular DSD Patient Results in the Retention of Intron 9.

Authors:  Dmytro Sirokha; Olexandra Gorodna; Yakov Vitrenko; Nataliya Zelinska; Rafal Ploski; Serge Nef; Jadwiga Jaruzelska; Kamila Kusz-Zamelczyk; Ludmila Livshits
Journal:  Biology (Basel)       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.